A detailed history of National Bank Of Canada transactions in X Biotech Inc. stock. As of the latest transaction made, National Bank Of Canada holds 33,000 shares of XBIT stock, worth $219,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,000
Previous 33,000 -0.0%
Holding current value
$219,780
Previous $255,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$4.03 - $8.13 $34,871 - $70,348
8,653 Added 35.54%
33,000 $268,000
Q4 2023

Feb 06, 2024

BUY
$3.56 - $4.65 $86,675 - $113,213
24,347 New
24,347 $97,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.